KUALA LUMPUR, June 5 (Bernama) -- At the closing ceremony of the European Academy of Allergy and Clinical Immunology (EAACI) Congress, Professor of Medicine and Head of the Allergology Service of the Regional University Hospital of Malaga, Dr María José Torres has assumed the role of EAACI new President.
The EAACI Congress 2024, a meeting forum for experts in Allergy and Immunology from countries all over the world, witnessed Dr Torres becoming the first Spanish professional to hold this position, according to a statement.
In her speech at the plenary session titled “Drug allergy: today and tomorrow”, Dr Torres stressed that drug allergy is a huge burden on healthcare systems and represents, in some cases, a threat to the patient's life.
Responding to a significant increase in interest in the design of predictive models to stratify patients' risk of being allergic, in recent years, she added that it is essential to continue researching and working towards the goal of efficient precision medicine.
Meanwhile, Dr Ioana Agache, who chairs EAACI's Research and Outreach Committee (ROC), details that with allergic diseases and asthma as prototypical environmentally driven diseases, Planetary Health is another key feature of EAACI's research agenda.
“The ERN (EAACI Research Network) seeks to identify and coordinate allergy and asthma research in Europe, which currently includes almost 100 institutions from Europe and around the world.
“It should guide the future of allergy and asthma research in Europe and foster synergies and cooperation, reduce duplication of efforts and identify gaps and priorities that need the attention of funding organisations,” Agache concludes.
-- BERNAMA
No comments:
Post a Comment